Postmenopausal Osteoporosis Therapeutics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Bisphosphonates
1.2.3 Hormones
1.2.4 Strontium Ranelate
1.2.5 Raloxifene
1.2.6 Denosumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postmenopausal Osteoporosis Therapeutics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Postmenopausal Osteoporosis Therapeutics Market Perspective (2018-2030)
2.2 Postmenopausal Osteoporosis Therapeutics Growth Trends by Region
2.2.1 Postmenopausal Osteoporosis Therapeutics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Postmenopausal Osteoporosis Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Region (2023-2030)
2.3 Postmenopausal Osteoporosis Therapeutics Market Dynamics
2.3.1 Postmenopausal Osteoporosis Therapeutics Industry Trends
2.3.2 Postmenopausal Osteoporosis Therapeutics Market Drivers
2.3.3 Postmenopausal Osteoporosis Therapeutics Market Challenges
2.3.4 Postmenopausal Osteoporosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue
3.1.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Postmenopausal Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postmenopausal Osteoporosis Therapeutics Revenue
3.4 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio
3.4.1 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postmenopausal Osteoporosis Therapeutics Revenue in 2022
3.5 Postmenopausal Osteoporosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
3.7 Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postmenopausal Osteoporosis Therapeutics Breakdown Data by Type
4.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2023-2030)
5 Postmenopausal Osteoporosis Therapeutics Breakdown Data by Application
5.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Postmenopausal Osteoporosis Therapeutics Market Size (2018-2030)
6.2 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
6.3 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size (2018-2030)
7.2 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
7.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size (2018-2030)
8.2 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Postmenopausal Osteoporosis Therapeutics Market Size (2018-2030)
9.2 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size (2018-2030)
10.2 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Postmenopausal Osteoporosis Therapeutics Introduction
11.1.4 Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Postmenopausal Osteoporosis Therapeutics Introduction
11.2.4 Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 F. Hoffman La Roche
11.3.1 F. Hoffman La Roche Company Detail
11.3.2 F. Hoffman La Roche Business Overview
11.3.3 F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Introduction
11.3.4 F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
11.3.5 F. Hoffman La Roche Recent Development
11.4 Procter & Gamble
11.4.1 Procter & Gamble Company Detail
11.4.2 Procter & Gamble Business Overview
11.4.3 Procter & Gamble Postmenopausal Osteoporosis Therapeutics Introduction
11.4.4 Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
11.4.5 Procter & Gamble Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Postmenopausal Osteoporosis Therapeutics Introduction
11.5.4 Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
11.5.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Bisphosphonates
Table 3. Key Players of Hormones
Table 4. Key Players of Strontium Ranelate
Table 5. Key Players of Raloxifene
Table 6. Key Players of Denosumab
Table 7. Key Players of Others
Table 8. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 9. Global Postmenopausal Osteoporosis Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 10. Global Postmenopausal Osteoporosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Postmenopausal Osteoporosis Therapeutics Market Share by Region (2018-2023)
Table 12. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 13. Global Postmenopausal Osteoporosis Therapeutics Market Share by Region (2023-2030)
Table 14. Postmenopausal Osteoporosis Therapeutics Market Trends
Table 15. Postmenopausal Osteoporosis Therapeutics Market Drivers
Table 16. Postmenopausal Osteoporosis Therapeutics Market Challenges
Table 17. Postmenopausal Osteoporosis Therapeutics Market Restraints
Table 18. Global Postmenopausal Osteoporosis Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players (2018-2023)
Table 20. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2022)
Table 21. Ranking of Global Top Postmenopausal Osteoporosis Therapeutics Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
Table 25. Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postmenopausal Osteoporosis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2018-2023)
Table 29. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 30. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2023-2030)
Table 31. Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application (2018-2023)
Table 33. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 34. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application (2023-2030)
Table 35. North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 37. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 39. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2023-2030) & (US$ Million)
Table 41. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 43. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 45. Eli Lilly Company Detail
Table 46. Eli Lilly Business Overview
Table 47. Eli Lilly Postmenopausal Osteoporosis Therapeutics Product
Table 48. Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
Table 49. Eli Lilly Recent Development
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Postmenopausal Osteoporosis Therapeutics Product
Table 53. Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. F. Hoffman La Roche Company Detail
Table 56. F. Hoffman La Roche Business Overview
Table 57. F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Product
Table 58. F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
Table 59. F. Hoffman La Roche Recent Development
Table 60. Procter & Gamble Company Detail
Table 61. Procter & Gamble Business Overview
Table 62. Procter & Gamble Postmenopausal Osteoporosis Therapeutics Product
Table 63. Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
Table 64. Procter & Gamble Recent Development
Table 65. Merck Company Detail
Table 66. Merck Business Overview
Table 67. Merck Postmenopausal Osteoporosis Therapeutics Product
Table 68. Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2018-2023) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postmenopausal Osteoporosis Therapeutics Market Share by Type: 2022 VS 2030
Figure 2. Bisphosphonates Features
Figure 3. Hormones Features
Figure 4. Strontium Ranelate Features
Figure 5. Raloxifene Features
Figure 6. Denosumab Features
Figure 7. Others Features
Figure 8. Global Postmenopausal Osteoporosis Therapeutics Market Share by Application in 2022 & 2030
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Postmenopausal Osteoporosis Therapeutics Report Years Considered
Figure 13. Global Postmenopausal Osteoporosis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 14. Global Postmenopausal Osteoporosis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 15. Global Postmenopausal Osteoporosis Therapeutics Market Share by Region: 2022 VS 2030
Figure 16. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players in 2022
Figure 17. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue in 2022
Figure 19. North America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 20. North America Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2030)
Figure 21. United States Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. Canada Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. Europe Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2030)
Figure 25. Germany Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. France Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. U.K. Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. Italy Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Russia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Nordic Countries Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Share by Region (2018-2030)
Figure 33. China Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Japan Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. South Korea Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. India Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Australia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Latin America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Latin America Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2030)
Figure 41. Mexico Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Brazil Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 44. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Share by Country (2018-2030)
Figure 45. Turkey Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 46. Saudi Arabia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
Figure 49. F. Hoffman La Roche Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
Figure 50. Procter & Gamble Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Industry Market Size
